| Lung Cancer |
0 |
0.89 |
| Cardiac Resynchronization Therapy |
0 |
0.85 |
| Non-Small Cell Lung Cancer |
0 |
1 |
| Small Cell Lung Cancer |
0 |
0.34 |
| Biologic Therapy |
0 |
0.28 |
| Lung |
0 |
0.26 |
| Interstitial Lung Disease |
0 |
0.23 |
| Cancer |
0 |
0.2 |
| Brachial |
0 |
0.13 |
| Europe |
0 |
0.07 |
| Health Care Quality, Access, and Evaluation |
0 |
0.99 |
| Histology |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Immunotherapy |
0 |
0.07 |
| Monoclonal Antibody |
0 |
0.07 |
| Platinum |
0 |
0.07 |
| Radiation Therapy |
0 |
0.98 |
| Social Determinants of Health |
0 |
0.07 |
| Travel Medicine |
0 |
0.07 |
| Tumor |
0 |
0.07 |